Latest filing published 30 Nov 2015 for ProPhase Labs, Inc., €19k.
Insider track record
No signal scores available.
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +30.6%Entry US$15.70 · Close at T+365 US$20.50
- +21.0%Entry US$15.70 · Close at T+365 US$19.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Mark S. Leventhal: trading record in brief
Mark S. Leventhal is a declared insider of ProPhase Labs, Inc., with filings sourced from SEC (Form 4). Between 13 July 2010 and 30 November 2015, the trades on record add up to 24 filings.
Purchases make up the whole of the open-market record (8 purchases, €255k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 16 share grants. In 2015 alone, the filings show 4 purchases and no sales.
Half of the purchases are above €20k and half below. After 4 purchases with a full 90-day history, the hit rate stands at 50% and the median 90-day move at +7.3%. These figures describe past trades and do not predict future prices.
The newest entry dates from 8 December 2015: an open-market purchase of €1,326, in ProPhase Labs, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mark S. Leventhal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 13,300 shares@ US$1.55Common Stock, par value $0.0005SEC:0001493152-15-005937:0
- 948 shares@ US$1.48Common Stock, par value $0.0005SEC:0001493152-15-005937:1
- 18,500 shares@ US$1.30Common Stock, par value $0.0005SEC:0001493152-15-005904:0
- 17,252 shares@ US$1.30Common Stock, par value $0.0005SEC:0001493152-15-005904:1
- 145,309 shares@ US$1.61Common Stock, par value $0.0005SEC:0001493152-15-003888:0
- 204,691 shares@ US$1.61Common Stock, par value $0.0005SEC:0001493152-15-003884:0
- 128,529 shares@ US$1.31Common Stock, par value $0.0005SEC:0001144204-15-036100:0
- 71,471 shares@ US$1.40Common Stock, par value $0.0005SEC:0001144204-15-036100:1
- 6,295 shares0Common Stock, par value $0.0005SEC:0001144204-15-000653:0
- 5,490 shares0Common Stock, par value $0.0005SEC:0001144204-13-039585:0
- 8,696 shares@ US$1.60Common Stock, par value $0.0005SEC:0001144204-13-027972:0Canonical exit: 6 Aug 2013 (T+90)
- 1,304 shares@ US$1.60Common Stock, par value $0.0005SEC:0001144204-13-027972:1Canonical exit: 7 Aug 2013 (T+90)
- 47,300 shares@ US$1.42Common Stock, par value $0.0005SEC:0001144204-12-065878:0Canonical exit: 26 Feb 2013 (T+90)
- 102,700 shares@ US$1.60Common Stock, par value $0.0005SEC:0001144204-12-065878:1Canonical exit: 27 Feb 2013 (T+90)
- 11,280 shares0Common Stock, par value $0.0005SEC:0001144204-11-056948:0
- 10,925 shares0Common Stock, par value $0.0005SEC:0001144204-11-040563:0
- 7,235 shares0Common Stock, par value $0.0005SEC:0001144204-11-022278:0
- 7,175 shares0Common Stock, par value $0.0005SEC:0001144204-11-005592:0
- 7,065 shares0Common Stock, par value $0.0005SEC:0001144204-10-061512:0
- 6,515 shares0Common Stock, par value $0.0005SEC:0001144204-10-037709:0
20 of 20 declarations